Logotype for iCAD Inc

iCAD (ICAD) investor relations material

iCAD has been acquired by RadNet Inc

iCAD Q1 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for iCAD Inc
Q1 2025 earnings summary13 May, 2025

Executive summary

  • Entered into a definitive merger agreement with RadNet, Inc. on April 15, 2025, with expected closing in Q2 or Q3 2025; each iCAD share to be exchanged for 0.0677 RadNet shares.

  • Q1 2025 total revenue was $4.9M, nearly flat year-over-year, with ARR up 18% to $10.7M.

  • Focused on AI-powered cancer detection, with the ProFound Breast Health Suite driving platform-based SaaS and DaaS growth.

  • Gross margin improved to 86% from 83% year-over-year, driven by higher-margin cloud revenues.

  • Operating expenses decreased 4% to $5.3M, and net loss narrowed to $0.8M from $1.2M in Q1 2024.

Financial highlights

  • Q1 2025 revenue: $4.9M, down from $5.0M in Q1 2024; product revenue up 4.6% to $3.2M, services revenue down 12% to $1.6M.

  • Gross profit increased to $4.2M (86% margin) from $4.1M (83% margin) year-over-year.

  • Operating loss improved to $(1.1)M from $(1.4)M in Q1 2024.

  • Net loss narrowed to $(0.8)M, or $(0.03) per share, compared to $(1.2)M, or $(0.05) per share, in Q1 2024.

  • Non-GAAP Adjusted Net Loss was $0.5M ($0.02/share), versus $1.2M ($0.05/share) last year.

Outlook and guidance

  • Management expects the merger with RadNet to close in Q2 or Q3 2025, subject to regulatory and shareholder approvals.

  • Anticipates continued shift toward subscription and cloud revenue, with marketing efforts aligned to accelerate this transition.

  • Liquidity and capital resources deemed sufficient to sustain operations for at least the next 12 months.

  • Expects to accelerate innovation and broaden access to AI-powered solutions through the pending RadNet acquisition.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

iCAD Inc. is a medical technology company focused on providing innovative solutions for cancer detection and therapy. The company develops advanced imaging and radiation therapy technologies, including artificial intelligence-based software for early cancer detection, particularly in mammography, and radiation therapy systems for treating cancerous tumors. iCAD’s products aim to improve diagnostic accuracy and treatment outcomes for patients while supporting healthcare providers with efficient and precise tools. The company is headquartered in Nashua, New Hampshire, and its shares are listed on the NASDAQ.